NewsStay Updated with the Latest News from 3billion.
International Case Reviews with Kuala Lumpur Hospital
3billion announces pathogenicity predictor ‘3Cnet’
3billion looks to 2022 IPO, expansion into drug discovery
Rare disease screening firm 3Billion closes $13M Series C financing
3billion aims for the global market by IPO
3billion Named “Next Unicorn” at ASEAN-Korea Scale-up Contest